Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 02, 2025 08:00 ET | Source: Immuneering Corporation

Immuneering to Present at the 24th Annual Needham Virtual Healthcare Conference

Immuneering to Present at the 24th Annual Needham Virtual Healthcare Conference
March 20, 2025 16:05 ET | Source: Immuneering Corporation

Immuneering Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates

Immuneering Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates
March 20, 2025 07:00 ET | Source: Immuneering Corporation

Immuneering Names Dr. Igor Matushansky as Chief Medical Officer

IMMUNEERING NAMES DR. IGOR MATUSHANSKY AS CHIEF MEDICAL OFFICER
February 03, 2025 16:05 ET | Source: Immuneering Corporation

Immuneering to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

Immuneering to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
January 07, 2025 07:00 ET | Source: Immuneering Corporation

Immuneering Announces Positive Data Update from Three Pancreatic Cancer Arms of Ongoing Phase 2a Trial of IMM-1-104; Plans to Expand Trial with Additional Arms

Immuneering Announces Positive Data Update from Three Pancreatic Cancer Arms of Ongoing Phase 2a Trial of IMM-1-104
December 17, 2024 08:00 ET | Source: Immuneering Corporation

Immuneering to Present Data from Three Arms of its Ongoing Phase 2a Trial of IMM-1-104 in Early January 2025

Immuneering to Present Data from Three Arms of its Ongoing Phase 2a Trial of IMM-1-104 in Early January 2025
December 12, 2024 08:00 ET | Source: Immuneering Corporation

Immuneering Granted FDA Fast Track Designation for IMM-1-104 in Advanced Melanoma

Immuneering Granted FDA Fast Track Designation for IMM-1-104 in Advanced Melanoma
November 27, 2024 08:00 ET | Source: Immuneering Corporation

Immuneering to Present at the Piper Sandler 36ᵗʰ Annual Healthcare Conference

Immuneering to Present at the Piper Sandler 36th Annual Healthcare Conference
November 13, 2024 16:05 ET | Source: Immuneering Corporation

Immuneering Reports Third Quarter 2024 Financial Results and Provides Business Updates

Immuneering Reports Third Quarter 2024 Financial Results and Provides Business Updates
October 15, 2024 08:00 ET | Source: Immuneering Corporation

Immuneering Granted Orphan Drug Designation for IMM-1-104 by FDA in the Treatment of Pancreatic Cancer

Immuneering Granted Orphan Drug Designation for IMM-1-104 by FDA in the Treatment of Pancreatic Cancer

Next Page keyboard_arrow_right